Four things to know:
1. Medicrea specializes in artificial intelligence, predictive modeling and patient-specific implants.
2. The transaction bolsters Medtronic’s expansion into AI, machine learning and predictive analytics.
3. The company has more than 30 implants that have received CE Mark or FDA approval. The products are designed for spinal deformity and degenerative disc disease.
4. Terms of the transaction were not disclosed.
More articles on devices:
The most controversial trends in spine from 10 surgeons
Dr. Ali Baaj to build UArizona-Banner spine program from scratch in new role
Investment firm bets big on spine device company that rejected Stryker takeover
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
